Parkinson Canada SuperWalk Toronto East

BlueRock Therapeutics

No Matter What.

Thanks for visiting our team page. This September, BlueRock Therapeutics will once again be joining the Parkinson community across Canada as part of Parkinson Canada SuperWalk. 

More than 25 Canadians are diagnosed with Parkinson's every day; more than one person every hour. By 2031, the number of people living with Parkinson’s in Canada will more than double. 

As a company, we’re fully committed to a future without Parkinson's. BlueRock Therapeutics is an engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases such as Parkinson's. The FDA has recently granted Fast Track designation for DA01 for advanced Parkinson's disease. DA01, BlueRock's pluripotent stem cell-derived dopaminergic neuron therapy, is under evaluation in a Phase 1 study.

We walk to show our collective support for a united movement of people in communities across Canada looking to make a difference one step at a time.

Help us ensure Parkinson Canada is there for Canadians living with Parkinson’s today – while funding research into better treatments and one day, a cure.

Every dollar raised counts. Thank you for your support!

View More
Team Name: BlueRock Therapeutics | Team Goal: $3,000.00

View More


Facebook Twitter
Youtube Flickr


Burnbrae Farms

Parkinson Canada

© Parkinson Canada
4211 Yonge Street
Suite 316
Toronto ON M2P 2A9

Charitable Registration Number 10809 1786 RR0001

Phone: 416-227-9700
Toll Free: 1-800-565-3000
Fax: 416-227-9600

Parkinson Canada is accredited by Imagine Canada's Standards program, recognizing a quality of excellence in five fundamental areas: board governance, financial accountability and transparency, fundraising, staff management, and volunteer involvement.

Parkinson Canada